- Home
- Publications
- Publication Search
- Publication Details
Title
Rationally Designed Ruthenium Complexes for Breast Cancer Therapy
Authors
Keywords
-
Journal
MOLECULES
Volume 25, Issue 2, Pages 265
Publisher
MDPI AG
Online
2020-01-10
DOI
10.3390/molecules25020265
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synthesis and biological assessment of a ruthenium(II) cyclopentadienyl complex in breast cancer cells and on the development of zebrafish embryos
- (2020) Golara Golbaghi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Development of Natural Product-Conjugated Metal Complexes as Cancer Therapies
- (2019) Dik-Lung Ma et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Transport of the ruthenium complex [Ru(GA)(dppe)2]PF6 into triple negative breast cancer cells is facilitated by transferrin receptors
- (2019) Marina A. Naves et al. MOLECULAR PHARMACEUTICS
- Organoruthenium(II) Complexes Bearing an Aromatase Inhibitor: Synthesis, Characterization, in Vitro Biological Activity and in Vivo Toxicity in Zebrafish Embryos
- (2019) Golara Golbaghi et al. ORGANOMETALLICS
- Breast Cancer Treatment
- (2019) Adrienne G. Waks et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry
- (2019) Enzo Alessio et al. MOLECULES
- Ruthenium–Cyclopentadienyl Bipyridine–Biotin Based Compounds: Synthesis and Biological Effect
- (2019) Leonor Côrte-Real et al. INORGANIC CHEMISTRY
- Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer
- (2019) Marialuisa Piccolo et al. Scientific Reports
- Non-platinum complexes containing releasable biologically active ligands
- (2019) Pavel Štarha et al. COORDINATION CHEMISTRY REVIEWS
- An estrogen receptor targeted ruthenium complex as a two-photon photodynamic therapy agent for breast cancer cells
- (2018) Xueze Zhao et al. CHEMICAL COMMUNICATIONS
- Ruthenium(ii) arene NSAID complexes: inhibition of cyclooxygenase and antiproliferative activity against cancer cell lines
- (2018) Poulami Mandal et al. DALTON TRANSACTIONS
- The side effects of platinum-based chemotherapy drugs: a review for chemists
- (2018) Rabbab Oun et al. DALTON TRANSACTIONS
- The trans -[Ru(PPh 3 ) 2 ( N , N -dimethyl- N ′-thiophenylthioureato-k 2 O,S)(bipy)]PF 6 complex has pro-apoptotic effects on triple negative breast cancer cells and presents low toxicity in vivo
- (2018) Amanda Blanque Becceneri et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Phosphine/diimine ruthenium complexes with Cl − , CO, NO + , NO 2 − , NO 3 − and pyridine ligands: Pro-apoptotic activity on triple-negative breast cancer cells and DNA/HSA interactions
- (2018) Henrique Vieira Reis Silva et al. POLYHEDRON
- Glutathione transferases: substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseases
- (2018) Nerino Allocati et al. Oncogenesis
- Metastatic and triple-negative breast cancer: challenges and treatment options
- (2018) Sumayah Al-Mahmood et al. Drug Delivery and Translational Research
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Half-sandwich Os(ii) and Ru(ii) bathophenanthroline complexes: anticancer drug candidates with unusual potency and a cellular activity profile in highly invasive triple-negative breast cancer cells
- (2018) Jitka Pracharova et al. DALTON TRANSACTIONS
- Potentiating apoptosis and modulation of p53, Bcl2, and Bax by a novel chrysin ruthenium complex for effective chemotherapeutic efficacy against breast cancer
- (2018) Souvik Roy et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433
- (2018) Susan Monro et al. CHEMICAL REVIEWS
- Unprecedented inhibition of P-gp activity by a novel ruthenium-cyclopentadienyl compound bearing a bipyridine-biotin ligand
- (2018) Leonor Côrte-Real et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The principles and applications of avidin-based nanoparticles in drug delivery and diagnosis
- (2017) Akshay Jain et al. JOURNAL OF CONTROLLED RELEASE
- A Molecular Combination of Zinc(II) Phthalocyanine and Tamoxifen Derivative for Dual Targeting Photodynamic Therapy and Hormone Therapy
- (2017) Feng-Ling Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cisplatin nephrotoxicity: a review of the literature
- (2017) Sandhya Manohar et al. JOURNAL OF NEPHROLOGY
- A Liposome Encapsulated Ruthenium Polypyridine Complex as a Theranostic Platform for Triple-Negative Breast Cancer
- (2017) Jianliang Shen et al. NANO LETTERS
- Diruthenium(ii,iii) metallodrugs of ibuprofen and naproxen encapsulated in intravenously injectable polymer–lipid nanoparticles exhibit enhanced activity against breast and prostate cancer cells
- (2017) Samara R. Alves Rico et al. Nanoscale
- 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
- (2017) Hongchao Pan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Potential role of CYP1B1 in the development and treatment of metabolic diseases
- (2017) Fei Li et al. PHARMACOLOGY & THERAPEUTICS
- Ruthenium(II)/triphenylphosphine complexes: An effective way to improve the cytotoxicity of lapachol
- (2017) Katia M. Oliveira et al. POLYHEDRON
- Synthesis, characterization and biological evaluation of ruthenium flavanol complexes against breast cancer
- (2017) Ashok Kumar Singh et al. SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
- Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action
- (2017) Carlo Irace et al. Scientific Reports
- Cortisol overproduction results from DNA methylation of CYP11B1 in hypercortisolemia
- (2017) Mitsuhiro Kometani et al. Scientific Reports
- Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells
- (2017) Cecília P. Popolin et al. PLoS One
- Tumoral expression of drug and xenobiotic metabolizing enzymes in breast cancer patients of different ethnicities with implications to personalized medicine
- (2017) Yan Li et al. Scientific Reports
- In vivo Performance of a Ruthenium-cyclopentadienyl Compound in an Orthotopic 1 Triple Negative Breast Cancer Model
- (2016) Nuno Mendes et al. Anti-Cancer Agents in Medicinal Chemistry
- Renewed interest in the progesterone receptor in breast cancer
- (2016) Elgene Lim et al. BRITISH JOURNAL OF CANCER
- EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape
- (2016) S.-O. Lim et al. CANCER RESEARCH
- BRCA1-Associated Triple-Negative Breast Cancer and Potential Treatment for Ruthenium-Based Compounds
- (2016) Khwanjira Hongthong et al. CURRENT CANCER DRUG TARGETS
- Thirty Years of the Drug Candidate NAMI-A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective
- (2016) Enzo Alessio EUROPEAN JOURNAL OF INORGANIC CHEMISTRY
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- The water soluble ruthenium(II) organometallic compound [Ru( p -cymene)(bis(3,5 dimethylpyrazol-1-yl)methane)Cl]Cl suppresses triple negative breast cancer growth by inhibiting tumor infiltration of regulatory T cells
- (2016) Maura Montani et al. PHARMACOLOGICAL RESEARCH
- Ruthenium(II) Complexes Containing Anti-Inflammatory Drugs as Ligands: Synthesis, Characterization andin vitroCytotoxicity Activities on Cancer Cell Lines
- (2015) Junai C. S. Lopes et al. JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY
- Discovery of a dual-targeting organometallic ruthenium complex with high activity inducing early stage apoptosis of cancer cells
- (2015) Jun Du et al. Metallomics
- Zebrafish as tools for drug discovery
- (2015) Calum A. MacRae et al. NATURE REVIEWS DRUG DISCOVERY
- Combination of Ru(ii) complexes and light: new frontiers in cancer therapy
- (2015) Cristina Mari et al. Chemical Science
- Ruthenium Polypyridyl Complex Inhibits Growth and Metastasis of Breast Cancer Cells by Suppressing FAK signaling with Enhancement of TRAIL-induced Apoptosis
- (2015) Wenqiang Cao et al. Scientific Reports
- Optimal management of hormone receptor positive metastatic breast cancer in 2016
- (2015) Tomas Reinert et al. Therapeutic Advances in Medical Oncology
- Cellular responses of BRCA1-defective and triple-negative breast cancer cells and in vitro BRCA1 interactions induced by metallo-intercalator ruthenium(II) complexes containing chloro-substituted phenylazopyridine
- (2014) Tidarat Nhukeaw et al. BMC CANCER
- Metal-based anticancer chemotherapeutic agents
- (2014) Nafees Muhammad et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- In Vitro and in Vivo Evaluation of Water-Soluble Iminophosphorane Ruthenium(II) Compounds. A Potential Chemotherapeutic Agent for Triple Negative Breast Cancer
- (2014) Malgorzata Frik et al. JOURNAL OF MEDICINAL CHEMISTRY
- In vivo anti-tumor activity of the organometallic ruthenium(ii)-arene complex [Ru(η6-p-cymene)Cl2(pta)] (RAPTA-C) in human ovarian and colorectal carcinomas
- (2014) Andrea Weiss et al. Chemical Science
- NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
- (2014) Robert Trondl et al. Chemical Science
- Luminescent iminophosphorane gold, palladium and platinum complexes as potential anticancer agents
- (2014) Malgorzata Frik et al. Inorganic Chemistry Frontiers
- Growth inhibitory activity for cancer cell lines of lapachol and its natural and semi-synthetic derivatives
- (2013) Serena Fiorito et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Gallic acid: Molecular rival of cancer
- (2013) Sharad Verma et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- Multi-targeted organometallic ruthenium(II)–arene anticancer complexes bearing inhibitors of poly(ADP-ribose) polymerase-1: A strategy to improve cytotoxicity
- (2013) Zhigang Wang et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Lapachol and its congeners as anticancer agents: a review
- (2013) Francesco Epifano et al. PHYTOCHEMISTRY REVIEWS
- Enzyme inhibition by metal complexes: concepts, strategies and applications
- (2013) Kelly J. Kilpin et al. Chemical Science
- Interaction of apo-transferrin with anticancer ruthenium complexes NAMI-A and its reduced form
- (2012) Olga Mazuryk et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Synthesis of organometallic ruthenium(II) complexes with strong activity against several human cancer cell lines
- (2012) Tânia S. Morais et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- New Ruthenium(II)–Letrozole Complexes as Anticancer Therapeutics
- (2012) Annie Castonguay et al. JOURNAL OF MEDICINAL CHEMISTRY
- Organometallic Palladium Complexes with a Water-Soluble Iminophosphorane Ligand As Potential Anticancer Agents
- (2012) Monica Carreira et al. ORGANOMETALLICS
- Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs
- (2011) Alberta Bergamo et al. DALTON TRANSACTIONS
- A Potent Ruthenium(II) Antitumor Complex Bearing a Lipophilic Levonorgestrel Group
- (2011) José Ruiz et al. INORGANIC CHEMISTRY
- A bifunctional organometallic ruthenium drug with multiple modes of inducing apoptosis
- (2011) Soumya Chatterjee et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Insight into the binding interactions of CYP450 aromatase inhibitors with their target enzyme: a combined molecular docking and molecular dynamics study
- (2011) Roberta Galeazzi et al. JOURNAL OF MOLECULAR MODELING
- Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
- (2011) Ana-Maria Florea et al. Cancers
- Mechanism-Based Tumor-Targeting Drug Delivery System. Validation of Efficient Vitamin Receptor-Mediated Endocytosis and Drug Release
- (2010) Shuyi Chen et al. BIOCONJUGATE CHEMISTRY
- Cisplatin–gemcitabine therapy in metastatic breast cancer: Improved outcome in triple negative breast cancer patients compared to non-triple negative patients
- (2010) Nebu Koshy et al. BREAST
- Poly(ADP-Ribose) Polymerase Inhibition: "Targeted" Therapy for Triple-Negative Breast Cancer
- (2010) C. K. Anders et al. CLINICAL CANCER RESEARCH
- Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin
- (2010) Igor P. Pogribny et al. INTERNATIONAL JOURNAL OF CANCER
- Dichloroacetate shifts the metabolism from glycolysis to glucose oxidation and exhibits synergistic growth inhibition with cisplatin in HeLa cells
- (2010) Fang INTERNATIONAL JOURNAL OF ONCOLOGY
- FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells
- (2010) J. M.-M. Kwok et al. MOLECULAR CANCER RESEARCH
- (Arene)Cl2Ru(II) complexes with N-coordinated estrogen and androgen isonicotinates: Interaction with sex hormone binding globulin and anticancer activity
- (2010) Rainer Schobert et al. STEROIDS
- Mitochondrial Uncoupling and the Warburg Effect: Molecular Basis for the Reprogramming of Cancer Cell Metabolism
- (2009) I. Samudio et al. CANCER RESEARCH
- Synthesis of Apoptosis-Inducing Iminophosphorane Organogold(III) Complexes and Study of Their Interactions with Biomolecular Targets
- (2009) Neha Shaik et al. INORGANIC CHEMISTRY
- New Derivatives of Vitamin B12 Show Preferential Targeting of Tumors
- (2008) R. Waibel et al. CANCER RESEARCH
- Chemopreventive effects of natural dietary compounds on cancer development
- (2008) Min-Hsiung Pan et al. CHEMICAL SOCIETY REVIEWS
- New trends for metal complexes with anticancer activity
- (2008) Pieter CA Bruijnincx et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Targeted therapy for cancer using PARP inhibitors
- (2008) Christopher J Lord et al. CURRENT OPINION IN PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now